PeptiDream (TSE:4587) Other Financing: 円-215 Mil (TTM As of Mar. 2026)


TSE:4587 PeptiDream Inc TSE:4587
72 GF Score
Price 円1,022.50
GF Value 円1,664.61
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PeptiDream Other Financing?

PeptiDream TSE:4587 72 Other Financing is 円-215 Mil as of Mar. 2026. GuruFocus rates TSE:4587 with a GF Score™ of 72/100 and a GF Value™ of 円1,664.61 (Possible Value Trap). The stock has 4 warning signs investors should review.

PeptiDream's Other Financing for the three months ended in Mar. 2026 was 円-148 Mil.

PeptiDream's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was 円-215 Mil.

PeptiDream Other Financing Historical Data

* Premium members only.

The historical data trend for PeptiDream's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PeptiDream Other Financing Chart

PeptiDream Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.49 -212.80 -38.00 0.00 -67.32

PeptiDream Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 -67.32 -147.79
TSE:4587
72GF Score
PeptiDream Inc TSE:4587
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PeptiDream Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-215 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of 円-215 Mil mean?
PeptiDream (TSE:4587) has a Other Financing of 円-215 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for PeptiDream and its competitors.
Is PeptiDream's Other Financing too high?
PeptiDream's current Other Financing is 円-215 Mil. Overall, PeptiDream has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PeptiDream's Other Financing compare to VRTX and REGN?
PeptiDream's Other Financing of 円-215 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for PeptiDream and its competitors. PeptiDream's current Other Financing is 円-215 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PeptiDream stock overvalued right now?
Based on GuruFocus' analysis, PeptiDream (TSE:4587) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,664.61, compared to a current price of 円1,022.50 — trading 38.6% below its estimated fair value. The current Other Financing is 円-215 Mil. PeptiDream's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For PeptiDream (TSE:4587), the current Other Financing is 円-215 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PeptiDream (TSE:4587) Overvalued in 2026?

Based on GuruFocus' analysis, PeptiDream stock appears to be undervalued. The current stock price of 円1,022.50 is trading 38.6% below its estimated GF Value™ of 円1,664.61. GuruFocus considers PeptiDream to be Possible Value Trap.

Key valuation signals for TSE:4587:

  • Other Financing: 円-215 Mil
  • GF Value™: 円1,664.61 vs. price of 円1,022.50 (38.6% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the TSE:4587 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PeptiDream Business Description

Other Exchanges PPTDF:USA
Address 3-25-23 Tonomachi, Kawasaki-ku, Kanagawa Prefecture, Kawasaki, JPN, 210-0821
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
72GF Score

Get the complete analysis for TSE:4587

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,022.50
Price
円1,664.61
GF Value